Author

C. K. Hahn

Institution: Dana-Farber Cancer Institute

Observed institutions: Broad Institute, Universidad de Oviedo, Southern University of Science and Technology, Dana-Farber Cancer Institute, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer

OpenAlex ID: A5008892944

227 | Rituximab and Epcoritamab as First‐line Therapy for Patients With High‐tumor Burden Follicular Lymphoma: First Results of a Multicenter Phase Ii Trial

2025 · R. Merryman, D. S. Wallace, et al. · Hematological Oncology · 1

P1282: Disease-specific U1 Spliceosomal Rna Mutations in Mature B-cell Neoplasms

2022 · F. Nadeu, S. Shuai, et al. · HemaSphere

Works count: 2

Citation count: 1

H-index: 1

I10-index: